MARKET

GRFS

GRFS

Grifols S A
NASDAQ
7.28
-0.12
-1.62%
After Hours: 7.28 0 0.00% 16:10 06/22 EDT
OPEN
7.38
PREV CLOSE
7.40
HIGH
7.43
LOW
7.26
VOLUME
691.08K
TURNOVER
--
52 WEEK HIGH
10.96
52 WEEK LOW
7.26
MARKET CAP
5.01B
P/E (TTM)
9.37
1D
5D
1M
3M
1Y
5Y
1D
Grifols Reshapes Board and ESG Committee Following Director Resignation
TipRanks · 11h ago
Grifols names Ester Masllorens Llinàs to board as independent director after Felip Font resignation
PUBT · 11h ago
Weekly Report: what happened at GRFS last week (0615-0619)?
Weekly Report · 19h ago
Grifols Shareholders Approve 2025 Accounts and July Dividend, Renew Deloitte Mandate
TipRanks · 4d ago
Grifols shareholders approve up to 10% share capital cut via treasury share cancellations
PUBT · 4d ago
Rigel Pharmaceuticals publishes corporate presentation outlining commercial growth strategy and pipeline priorities
PUBT · 6d ago
Grifols announces U.S. launch of new fibrinogen concentrate
TipRanks · 06/15 12:50
GRIFOLS - ANNOUNCES U.S. LAUNCH OF NEW FIBRINOGEN CONCENTRATE
Reuters · 06/15 12:05
More
About GRFS
Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. The Company organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Its diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Its bio Supplies provides, mostly, biological products for non-therapeutic use.

Webull offers Grifols SA - ADR stock information, including NASDAQ: GRFS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GRFS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GRFS stock methods without spending real money on the virtual paper trading platform.